Treatment of allergic disease can broadly be split into two categories, both of which are equally as important to consider:
In the early stages of the diagnosis and disease, it is important to provide both the animal and owner with short term relief from the clinical signs. However, it’s crucial not to forget the need for a long-term strategy for this lifelong condition. A flexible and multi-modal approach, which includes a method for controlling the primary disease, is the best option for achieving sustained success.
Allergen specific immunotherapy remains the only therapy capable of modifying the natural course of a pre-existing hypersensitivity, resulting in the establishment of long-term clinical tolerance1,2.
Allergen-specific immunotherapy is a proven, effective treatment for allergies. Over time, injected allergens stimulate the immune system with the aim of reaching immunological tolerance. This type of therapy is recommended by The International Committee on Allergic Diseases of Animals (ICADA), and is widely used by dermatologists to target the root cause of allergy.
There is currently an ongoing (potentially long-term) supply issue for this therapy.
Unfortunately, at this time point, we are unable to give an indication of when the product may be available again.
If you would like to be updated with further information regarding availability, have any questions or would like to discuss this further, please contact our Technical Support Team at technical.support@avacta.com or phone on 0800 3 047 047.
Please accept our apologies for any inconvenience or concerns this situation may cause.
Allergen-Specific Immunotherapy (ASIT) - tailor-made for each patient
Allergen-specific immunotherapy is a proven, effective treatment for allergies. Over time, injected allergens stimulate the immune system with the aim of reaching immunological tolerance. This type of therapy is recommended by The International Committee on Allergic Diseases of Animals (ICADA), and is widely used by dermatologists to target the root cause of allergy.
Key Points:
Administration and dosage:
Staphage Lysate® (SPL) - a long-term solution for recurrent canine pyoderma
Staphage Lysate®
There is a currently an ongoing (potentially long-term) supply issue for this therapy. Unfortunately, at this time point, we are unable to give an indication of when the product may be available again.
If you would like to be updated with further information regarding availability, have any questions or would like to discuss this further, please contact our Technical Support Team at technical.support@avacta.com or phone on 0800 3 047 047.
Please accept our apologies for any inconvenience or concerns this situation may cause.
References